Kenvue Inc. (NYSE:KVUE) Shares Purchased by Viking Fund Management LLC

Viking Fund Management LLC boosted its holdings in Kenvue Inc. (NYSE:KVUE) by 16.2% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 280,000 shares of the company’s stock after buying an additional 39,000 shares during the quarter. Viking Fund Management LLC’s holdings in Kenvue were worth $6,009,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in KVUE. Planned Solutions Inc. acquired a new position in Kenvue in the fourth quarter worth approximately $27,000. Pacific Capital Wealth Advisors Inc. purchased a new position in Kenvue during the 4th quarter worth approximately $28,000. Mather Group LLC. purchased a new position in Kenvue during the 1st quarter worth approximately $28,000. CVA Family Office LLC purchased a new position in Kenvue during the 4th quarter worth approximately $32,000. Finally, Pinnacle Bancorp Inc. grew its position in Kenvue by 51.3% during the 4th quarter. Pinnacle Bancorp Inc. now owns 1,552 shares of the company’s stock worth $33,000 after purchasing an additional 526 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Ratings Changes

KVUE has been the topic of several research analyst reports. Sanford C. Bernstein initiated coverage on shares of Kenvue in a research report on Thursday, April 11th. They set an “underperform” rating and a $18.00 price objective on the stock. William Blair initiated coverage on shares of Kenvue in a research report on Wednesday, April 3rd. They set a “market perform” rating on the stock. The Goldman Sachs Group initiated coverage on shares of Kenvue in a research report on Friday, March 1st. They set a “neutral” rating and a $20.00 price objective on the stock. HSBC lifted their price objective on shares of Kenvue from $20.00 to $21.00 and gave the stock a “hold” rating in a research report on Wednesday, May 8th. Finally, Citigroup reissued a “neutral” rating and set a $21.00 target price on shares of Kenvue in a research note on Tuesday, May 28th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $23.09.

Kenvue Stock Down 0.6 %

Shares of KVUE stock traded down $0.11 on Thursday, hitting $18.48. The company’s stock had a trading volume of 8,728,491 shares, compared to its average volume of 19,217,393. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.99 and a quick ratio of 0.68. Kenvue Inc. has a fifty-two week low of $17.75 and a fifty-two week high of $26.66. The firm’s fifty day moving average price is $19.24 and its 200-day moving average price is $20.01. The stock has a market capitalization of $35.39 billion and a price-to-earnings ratio of 23.83.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Tuesday, May 7th. The company reported $0.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.03. Kenvue had a net margin of 9.63% and a return on equity of 21.06%. The business had revenue of $2.89 billion during the quarter, compared to analyst estimates of $3.79 billion. The business’s revenue was down 24.9% on a year-over-year basis. Research analysts anticipate that Kenvue Inc. will post 1.17 EPS for the current year.

Kenvue Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 22nd. Investors of record on Wednesday, May 8th were paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 4.33%. The ex-dividend date of this dividend was Tuesday, May 7th. Kenvue’s payout ratio is presently 102.56%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.